Gene · 8317
Papers1,550
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 1,550
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Snapshot imprinting as a tool for surface mapping and identification of novel biomarkers of senescent cells. | Nanoscale Adv | 2022 | 36540121 | PubTator, text mining | PubMed |
| Differentially Expressed Cell Cycle Genes and STAT1/3-Driven Multiple Cancer Entanglement in Psoriasis, Coupled with Other Comorbidities. | Cells | 2022 | 36497125 | PubTator, text mining | PubMed |
| Ethnic and racial-specific differences in levels of centrosome-associated mitotic kinases, proliferative and epithelial-to-mesenchymal markers in breast cancers. | Cell Div | 2022 | 36494865 | PubTator, text mining | PubMed |
| CDC7 Expression in Selected Odontogenic Tumors. | Int J Dent | 2022 | 36483932 | PubTator, text mining | PubMed |
| Breast cancer cells survive chemotherapy by activating targetable immune-modulatory programs characterized by PD-L1 or CD80. | Nat Cancer | 2022 | 36482233 | PubTator, text mining | PubMed |
| Genomic profiling and network-level understanding uncover the potential genes and the pathways in hepatocellular carcinoma. | Front Genet | 2022 | 36479247 | PubTator, text mining | PubMed |
| MCM4 is a novel prognostic biomarker and promotes cancer cell growth in glioma. | Front Oncol | 2022 | 36465369 | PubTator, text mining | PubMed |
| Genetic variant in miR-17-92 cluster binding sites is associated with esophageal squamous cell carcinoma risk in Chinese population. | BMC Cancer | 2022 | 36461008 | PubTator, text mining | PubMed |
| The N-Myc-responsive lncRNA MILIP promotes DNA double-strand break repair through non-homologous end joining. | Proc Natl Acad Sci U S A | 2022 | 36445966 | PubTator, text mining | PubMed |
| Degree of stemness predicts micro-environmental response and clinical outcomes of diffuse large B-cell lymphoma and identifies a potential targeted therapy. | Front Immunol | 2022 | 36426371 | PubTator, text mining | PubMed |
| Advances with metal oxide-based nanoparticles as MDR metastatic breast cancer therapeutics and diagnostics. | RSC Adv | 2022 | 36425155 | PubTator, text mining | PubMed |
| Investigation of key signaling pathways and appropriate diagnostic biomarkers selection between non-invasive to invasive stages in pancreatic cancer: a computational observation. | J Med Life | 2022 | 36415513 | PubTator, text mining | PubMed |
| Monoallelic variants resulting in substitutions of MAB21L1 Arg51 Cause Aniridia and microphthalmia. | PLoS One | 2022 | 36413568 | PubTator, text mining | PubMed |
| Accurate Identification of DNA Replication Origin by Fusing Epigenomics and Chromatin Interaction Information. | Research (Wash D C) | 2022 | 36405252 | PubTator, text mining | PubMed |
| Ubiquitin-assisted phase separation of dishevelled-2 promotes Wnt signalling. | J Cell Sci | 2022 | 36398662 | PubTator, text mining | PubMed |
| Proteogenomic analysis of lung adenocarcinoma reveals tumor heterogeneity, survival determinants, and therapeutically relevant pathways. | Cell Rep Med | 2022 | 36384096 | PubTator, text mining | PubMed |
| WEE1 inhibition augments CDC7 (DDK) inhibitor-induced cell death in Ewing sarcoma by forcing premature mitotic entry and mitotic catastrophe. | Cancer Res Commun | 2022 | 36338546 | PubTator, text mining | PubMed |
| Association between cognitive function and large optic nerve cupping, accounting for cup-disc-ratio genetic risk score. | PLoS One | 2022 | 36315511 | PubTator, text mining | PubMed |
| MCM2 in human cancer: functions, mechanisms, and clinical significance. | Mol Med | 2022 | 36303105 | PubTator, text mining | PubMed |
| Gemcitabine-Paclitaxel Chemotherapy for Patients with Advanced Urothelial Cancer Refractory to Cisplatin-Based Chemotherapy: Predictive Role of PGK1 for Treatment Response to Cytotoxic Chemotherapy. | Int J Mol Sci | 2022 | 36292976 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8317/papers?page=12